Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 344-348

  Platz, A ^a   Ringborg, U ^a   Lagerlof B ^a   Lundqvist, E ^b   Sevigny, P ^b   Inganas M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GE Healthcare Bio Sciences AB   (Sweden)

Author keywords

CDKN2 mutation; Human melanoma; Metastases; Polymerase chain reaction single strand conformation polymorphism; Sequence analysis

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA;

ARTICLE; CHROMOSOME 9P; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0030067374     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.59     Document Type: Article

References (21)

1. CAIRNS P, MAO L, MERLO A, LEE DJ, SCHWAB D, EBY Y, TOKINO K, VAN DER RIET P, BLAUGRUND JE AND SIDRANSKY D. (1994). Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-417.
2. CALDAS C, HAHN SA, DA COSTA LT, REDSTON MS, SCHUTTE M, SEYMOUR AB, WEINSTEIN CL, HRUBAN RH, YEO CJ AND KERN SE. (1994). Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32.
3. CANNON-ALBRIGHT LA, GOLDGAR ED, MEYER LJ, LEWIS CM, ANDERSON DE, FOUNTAIN JW, HEGI ME, WISHMAN RW, PETTY EM, BALE AE, OLOPADE OI, DIAZ MO, KWIATKOWSKI DJ, PIEPKORN MW, ZONE JJ AND SKOLNICK MH. (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13 p22. Science, 258, 1148-1152.
4. GOLDSTEIN AM, DRACOPOLI NC, HO EC, FRASER MC, KEARNS KS, BALE SJ, MCBRIDE OW, CLARK JR WH AND TUCKER MA. (1993). Further evidence for a locus for cutaneous malignant melonoma dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am. J. Hum. Genet, 52, 537-550.
5. GREENE MH, CLARK WH JR, TUCKER MA, KRAEMER KH, ELDER DE AND FRASER MC. (1985). High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann. Intern. Med., 102, 458-465.
6. GRUIS NA, WEAVER-FELDHAUS J, LIU Q, FRYE C, EELES R, ORLOW I, LACOMBE L, PONCE-CASTANEDA V, LIANES P, LATRES E, SKOLNICK M, CORDON-CARDO C AND KAMB A. (1995). Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am. J. Pathol., 146, 1199-1206.
7. HANNON GJ AND BEACH D. (1994). p15 INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature, 371, 257-261.
8. HUSSUSSIAN CJ, STRUEWING JP, GOLDSTEIN AM, HIGGINS PAT, ALLY DS, SHEAHAN MD, CLARK WH JR, TUCKER MA AND DRACOPOLI NC. (1994). Germline p16 mutations in familial melanoma. Nature Genet., 8, 5-21.
9. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, LIU Q, HARSHMAN K, TAVTIGIAN SV, STOCKERT E, DAY III RF, JOHNSON BE AND SKOLNICK MH. (1994a). A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 426-440.
10. KAMB A, SHATTUCK-EIDENS D, EELES R, LIU Q, GRUIS NA, DING W, HUSSEY C, TRAN T, MIKI Y, WEAVER-FELDHAUS J, MCCLURE M, AITKEEN FJ, ANDERSON DE, BERGMAN W, FRANTS R, GOLDGAR DE, GREEN A, MACLENNAN R, MARTIN NG, MEYER LJ, YOUL P, ZONE JJ, SKOLNICK MH AND CANNON-ALBRIGHT LA. (1994b). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet., 8, 22-26.
11. LAGERKVIST A, STEWART J, LAGERSTRÖM-FERMER M AND LANDEGREN U. (1994). Manifold sequencing: Efficient processing of large sets of sequencing reactions. Proc. Natl Acad. Sci. USA, 91, 2245-2249.
12. MASHIYAMA S, SEKIYA T AND HAYASHI K. (1990). Screening of multiple DNA samples for detection of sequence changes. Technique - J Methods Cell. Mol. Biol., 2, 304-306.
13. MORI T, MIURA K, AOKI T, HISHIHIRA T, MORI S AND NAKAMURA Y. (1994). Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3394.
14. NOBORI T, MIURA K, WU DJ, LOIS A, TAKABAYASHI K AND CARSON DA. (1994). Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
15. OHTA M, NAGAR H, SHIMIZU M, RASIO D, BERD D, MASTRANGELO M, SINGH AD, SHIELD CL, CROCE CM AND HUEBNER K. (1994). Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41, in melonoma. Cancer Res. 54, 5269-5272.
16. ink4 in human cancer. Proc. Natl Acad. Sci. USA, 91, 11045-11049.
17. SERRANO M, HANNON GJ AND BEACH D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/ CDK4. Nature, 366, 704-707.
18. SPRUCK CH III, GONZALEZ-ZULUETA M, SHIBATA A, SIMONEAU AS, LIN M-F, GONZALES F, TSAI YC AND JONES PA. (1994). p16 gene in uncultured tumors. Nature, 370, 183-184.
19. VINCENT S, MARTY L AND FORT P. (1993). S26 ribosomal protein RNA: an invariant control for the gene regulation experiments in eucaryotic cells and tissues. Nucleic. Acids Res., 21, 1498.
20. XU L, SGROI D, STERNER CJ, BEAUCHAMP RL, PINNEY DM, KEEL S, UEKI K, RUTTER JL, BUCKLER AJ, LOUIS DN, GUSELLA JF AND RAMESH V. (1994). Mutational analysis of CDKN2 (MTS1/ p16 ink4) in human breast carcinomas. Cancer Res., 54, 5262-5264.
21. ZHANG S-Y, KLEIN-SZANTO AJP, SAUTER ER, SHAFERENKO M, MITSUNAGA S, NOBORI T, CARSON DA, RIDGE JA AND GOODROW TL. (1994). Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 50-53.